M&A Deal Summary

Elsevier BV Acquires Ariadne Genomics

On December 8, 2011, Elsevier BV acquired life science company Ariadne Genomics

Acquisition Highlights
  • This is Elsevier BV’s 1st transaction in the Life Science sector.
  • This is Elsevier BV’s 7th transaction in the United States.
  • This is Elsevier BV’s 1st transaction in Maryland.

M&A Deal Summary
Date 2011-12-08
Target Ariadne Genomics
Sector Life Science
Buyer(s) Elsevier BV
Deal Type Add-on Acquisition

Target

Ariadne Genomics

Rockville, Maryland, United States
Ariadne Genomics, Inc. is a provider of pathway analysis tools and semantic technologies for pharmaceutical and life science researchers.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Elsevier BV

Amsterdam, Netherlands
Category Company
Founded 1880
Sector Publishing
DESCRIPTION

Elsevier is a publishing company which publishes medical and scientific information. The Company is based in Amsterdam with additional operations in the United Kingdom, US, Mexico, Brazil, and Spain.

DEAL STATS #
Overall 9 of 29
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 9 of 26
State (Maryland) 1 of 1
Country (United States) 7 of 20
Year (2011) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-21 Shanghai Datong Medical Information Technology

Shanghai,, China

Shanghai Datong Medical Information Technology develops and offers drug decision support software for Chinese hospitals to improve drug usage safety and reduce prescription errors.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-09-11 MedQuest

Woodbury, Minnesota, United States

MedQuest LLC (dba ExitCare LLC) provides peer-reviewed patient education and discharge instructions to support clinicians, empower patients and help providers meet their patients’ educational needs.

Buy -
Mergr

Product

Company

Legal